Titre : Nucleoside-triphosphatase

Nucleoside-triphosphatase : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Nucleoside-Triphosphatase
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Nucleoside-triphosphatase : Questions médicales les plus fréquentes", "headline": "Nucleoside-triphosphatase : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Nucleoside-triphosphatase : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-15", "dateModified": "2026-05-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Nucleoside-triphosphatase" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acid anhydride hydrolases", "url": "https://questionsmedicales.fr/mesh/D017766", "about": { "@type": "MedicalCondition", "name": "Acid anhydride hydrolases", "code": { "@type": "MedicalCode", "code": "D017766", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.040" } } }, "about": { "@type": "MedicalCondition", "name": "Nucleoside-triphosphatase", "alternateName": "Nucleoside-Triphosphatase", "code": { "@type": "MedicalCode", "code": "D043583", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Elisabetta Groaz", "url": "https://questionsmedicales.fr/author/Elisabetta%20Groaz", "affiliation": { "@type": "Organization", "name": "Rega Institute for Medical Research, Medicinal Chemistry, KU Leuven, Herestraat 49-Box 1041, 3000, Leuven, Belgium." } }, { "@type": "Person", "name": "Fabian Hulpia", "url": "https://questionsmedicales.fr/author/Fabian%20Hulpia", "affiliation": { "@type": "Organization", "name": "Laboratory for Medicinal Chemistry, Campus Heymans (FFW), Ghent University, Ottergemsesteenweg 460, B-9000 Gent, Belgium." } }, { "@type": "Person", "name": "Serge Van Calenbergh", "url": "https://questionsmedicales.fr/author/Serge%20Van%20Calenbergh", "affiliation": { "@type": "Organization", "name": "Laboratory for Medicinal Chemistry, Campus Heymans (FFW), Ghent University, Ottergemsesteenweg 460, B-9000 Gent, Belgium." } }, { "@type": "Person", "name": "Maria I Kozlova", "url": "https://questionsmedicales.fr/author/Maria%20I%20Kozlova", "affiliation": { "@type": "Organization", "name": "School of Physics, Osnabrueck University, D-49069 Osnabrueck, Germany." } }, { "@type": "Person", "name": "Daria N Shalaeva", "url": "https://questionsmedicales.fr/author/Daria%20N%20Shalaeva", "affiliation": { "@type": "Organization", "name": "School of Physics, Osnabrueck University, D-49069 Osnabrueck, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Plasmodium RNA triphosphatase validation as antimalarial target.", "datePublished": "2024-04-26", "url": "https://questionsmedicales.fr/article/38810336", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijpddr.2024.100537" } }, { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.", "datePublished": "2023-06-22", "url": "https://questionsmedicales.fr/article/37347173", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/jvi.00512-23" } }, { "@type": "ScholarlyArticle", "name": "Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations.", "datePublished": "2024-08-08", "url": "https://questionsmedicales.fr/article/39116118", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0307902" } }, { "@type": "ScholarlyArticle", "name": "Atypical low-copy number plasmid segregation systems, all in one?", "datePublished": "2023-06-08", "url": "https://questionsmedicales.fr/article/37301314", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.plasmid.2023.102694" } }, { "@type": "ScholarlyArticle", "name": "Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease.", "datePublished": "2024-08-03", "url": "https://questionsmedicales.fr/article/39205224", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/v16081250" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Acid anhydride hydrolases", "item": "https://questionsmedicales.fr/mesh/D017766" }, { "@type": "ListItem", "position": 6, "name": "Nucleoside-triphosphatase", "item": "https://questionsmedicales.fr/mesh/D043583" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Nucleoside-triphosphatase - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Nucleoside-triphosphatase", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-06-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Nucleoside-triphosphatase", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D043583#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 05/05/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Elisabetta Groaz

3 publications dans cette catégorie

Affiliations :
  • Rega Institute for Medical Research, Medicinal Chemistry, KU Leuven, Herestraat 49-Box 1041, 3000, Leuven, Belgium.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via Marzolo 5, 35131, Padova, Italy.

Fabian Hulpia

3 publications dans cette catégorie

Affiliations :
  • Laboratory for Medicinal Chemistry, Campus Heymans (FFW), Ghent University, Ottergemsesteenweg 460, B-9000 Gent, Belgium.
Publications dans "Nucleoside-triphosphatase" :

Serge Van Calenbergh

3 publications dans cette catégorie

Affiliations :
  • Laboratory for Medicinal Chemistry, Campus Heymans (FFW), Ghent University, Ottergemsesteenweg 460, B-9000 Gent, Belgium.
Publications dans "Nucleoside-triphosphatase" :

Maria I Kozlova

2 publications dans cette catégorie

Affiliations :
  • School of Physics, Osnabrueck University, D-49069 Osnabrueck, Germany.

Daria N Shalaeva

2 publications dans cette catégorie

Affiliations :
  • School of Physics, Osnabrueck University, D-49069 Osnabrueck, Germany.

Daria V Dibrova

2 publications dans cette catégorie

Affiliations :
  • School of Physics, Osnabrueck University, D-49069 Osnabrueck, Germany.

Armen Y Mulkidjanian

2 publications dans cette catégorie

Affiliations :
  • School of Physics, Osnabrueck University, D-49069 Osnabrueck, Germany.
  • Center of Cellular Nanoanalytics, Osnabrueck University, D-49069 Osnabrueck, Germany.

Sergey N Mikhailov

2 publications dans cette catégorie

Affiliations :
  • Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str. 32, 119991 Moscow, Russia.
Publications dans "Nucleoside-triphosphatase" :

Xin Zhai

2 publications dans cette catégorie

Affiliations :
  • Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
Publications dans "Nucleoside-triphosphatase" :

Ning Zhang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Integrated Management of Insect Pests and Rodents, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Jesús Fernández-Lucas

2 publications dans cette catégorie

Affiliations :
  • Applied Biotechnology Group, Universidad Europea de Madrid, Urbanización El Bosque, Villaviciosa de Odón, 28670 Madrid, Spain.
  • Grupo de Investigación en Ciencias Naturales y Exactas, GICNEX, Universidad de la Costa, CUC, Calle 58 #55-66, Barranquilla 080002, Colombia.
  • Department of Biochemistry and Molecular Biology, Faculty of Biology, Universidad Complutense de Madrid, C. de José Antonio Novais, 12, 28040 Madrid, Spain.

Vincent Roy

2 publications dans cette catégorie

Affiliations :
  • ICOA, Univ. Orléans, CNRS UMR 7311, Université d'Orléans, Rue de Chartres, 45067, Orléans Cedex 2, France.
Publications dans "Nucleoside-triphosphatase" :

Luigi A Agrofoglio

2 publications dans cette catégorie

Affiliations :
  • ICOA, Univ. Orléans, CNRS UMR 7311, Université d'Orléans, Rue de Chartres, 45067, Orléans Cedex 2, France.
Publications dans "Nucleoside-triphosphatase" :

Harry P de Koning

2 publications dans cette catégorie

Affiliations :
  • Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, U.K.
Publications dans "Nucleoside-triphosphatase" :

Jennifer S Teichert

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Ludwig-Maximilians-University Munich, Butenandtstr. 5-13, 81377, Munich, Germany.
  • Max-Planck-Institute for Astronomy, Königstuhl 17, 69117, Heidelberg, Germany.
Publications dans "Nucleoside-triphosphatase" :

Florian M Kruse

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Ludwig-Maximilians-University Munich, Butenandtstr. 5-13, 81377, Munich, Germany.
Publications dans "Nucleoside-triphosphatase" :

Oliver Trapp

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, Ludwig-Maximilians-University Munich, Butenandtstr. 5-13, 81377, Munich, Germany.
  • Max-Planck-Institute for Astronomy, Königstuhl 17, 69117, Heidelberg, Germany.
Publications dans "Nucleoside-triphosphatase" :

Steven De Jonghe

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Publications dans "Nucleoside-triphosphatase" :

Cheol K Chung

2 publications dans cette catégorie

Affiliations :
  • Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States.
Publications dans "Nucleoside-triphosphatase" :

Piet Herdewijn

2 publications dans cette catégorie

Affiliations :
  • KU Leuven, Rega Institute for Medical Research , Medicinal Chemistry , Herestraat 49, Box 1041 , 3000 Leuven , Belgium.
Publications dans "Nucleoside-triphosphatase" :

Sources (275 au total)

Elucidating the inhibitory mechanism of Zika virus NS2B-NS3 protease with dipeptide inhibitors: Insights from molecular docking and molecular dynamics simulations.

Microcephaly, Guillain-Barré syndrome, and potential sexual transmission stand as prominent complications associated with Zika virus (ZIKV) infection. The absence of FDA-approved drugs or vaccines pre...

Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease.

The emergence of drug-resistance-inducing mutations in Hepatitis C virus (HCV) coupled with genotypic heterogeneity has made targeting NS3/4A serine protease difficult. In this work, we investigated t...

Engineering a Bifunctional Fusion Purine/Pyrimidine Nucleoside Phosphorylase for the Production of Nucleoside Analogs.

Nucleoside phosphorylases (NPs) are pivotal enzymes in the salvage pathway, catalyzing the reversible phosphorolysis of nucleosides to produce nucleobases and α-D-ribose 1-phosphate. Due to their effi...